According to a new report, published by KBV research, The Global Demineralized Bone Matrix Market size is expected to reach $1.9 billion by 2030, rising at a market growth of 5.6% CAGR during the forecast period.
Clinical guidelines and recommendations from professional organizations and regulatory bodies have played a significant role in promoting the adoption of DBM in clinical practice. Leading medical associations endorse using DBM as a viable bone graft substitute in various orthopedic and dental procedures, providing healthcare providers with evidence-based guidance on its appropriate use and application. By aligning with established clinical guidelines, healthcare providers feel confident in incorporating DBM into their treatment protocols, contributing to its widespread adoption.
Innovation is a driving force in the demineralized bone matrix market, continually reshaping the landscape of bone regeneration and orthopedic surgery. Manufacturers are continually refining processing techniques to enhance the quality, consistency, and biological activity of DBM grafting materials. Advanced processing methods, such as freeze-drying, supercritical CO2 extraction, and gamma irradiation, enable the production of DBM implants with optimized osteoinductive and osteoconductive properties.
The Hospitals segment would exhibit a CAGR of 5.9% during (2023 - 2030). Hospitals have specialized infrastructure, advanced medical equipment, and multidisciplinary healthcare teams capable of performing complex orthopedic and dental surgeries requiring DBM. Patients with severe musculoskeletal disorders or extensive bone defects may require surgical interventions that are best conducted in a hospital setting to ensure comprehensive care and optimal outcomes.
The Putty segment is generating highest revenue in the Global Demineralized Bone Matrix Market by Product Type in 2022; thereby, achieving a market value of $828.3 million by 2030. Demineralized bone matrix putty can be molded and shaped to conform to the specific contours of bone defects, making it suitable for various surgical applications. Surgeons can use DBM putty in spinal fusion surgeries, fracture repair procedures, dental implantology, and periodontal surgeries, addressing diverse clinical needs with a single grafting material.
The Dental segment is experiencing a CAGR of 5.3% during (2023 - 2030). There is a growing prevalence of dental conditions such as tooth loss, periodontal disease, and alveolar bone resorption, particularly among aging populations. As a result, there is an increasing need for dental procedures, including dental implant placement, ridge augmentation, and sinus lift procedures. These often require bone grafting with DBM to enhance bone volume and quality for successful implant integration.
Full Report: https://www.kbvresearch.com/demineralized-bone-matrix-market/
The North America region dominated the Global Demineralized Bone Matrix Market by Region in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $750.8 million by 2030. The Europe region is anticipated to grow at a CAGR of 5.2% during (2023 - 2030). Additionally, The Asia Pacific region would witness a CAGR of 6.5% during (2023 - 2030).
By End-use
By Product Type
By Application
By Geography
Unique Offerings 
